Stocks and Investing Stocks and Investing
Thu, May 11, 2023

Graig Suvannavejh Maintained (AXSM) at Strong Buy with Increased Target to $95 on, May 11th, 2023


Published on 2024-10-28 03:41:51 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Mizuho, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $84 to $95 on, May 11th, 2023.

Graig has made no other calls on AXSM in the last 4 months.



There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Graig's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $87 on, Tuesday, May 9th, 2023


These are the ratings of the 3 analyists that currently disagree with Graig


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $104 on, Tuesday, May 9th, 2023
  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $100 on, Tuesday, May 9th, 2023
  • Jason Gerberry of "B of A Securities" Reiterated at Sell and Held Target at $52 on, Tuesday, February 14th, 2023
Contributing Sources